This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Sarepta Therapeutics Inc
SRPT : NASDAQ : Health Care
$19.90 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 1,385,600
07/28/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
SRPT SAREPTA THERAPEUTICS INC 20.63 839.19 n/m 15.83 -48.25
INSY INSYS THERAPEUTICS INC 27.63 945.75 20.17 129.87 429.87
IMGN IMMUNOGEN INC 10.89 934.51 n/m 57.98 67.31
EBS EMERGENT BIOSOLUTIONS INC 22.94 858.21 44.98 323.53 17.78
AEGR AEGERION PHARMACEUTICALS INC 29.09 857.66 n/m 74.29 5934.76
BCRX BIOCRYST PHARMACEUTICALS INC 12.17 852.81 n/m 17.24 -2.22
SGMO SANGAMO BIOSCIENCES INC 12.26 833.19 n/m 31.08 22.36
GHDX GENOMIC HEALTH INC 26.65 832.60 n/m 265.50 10.71
EXEL EXELIXIS INC 4.21 819.67 n/m 26.57 -31.18
LXRX LEXICON PHARMACEUTICALS INC 1.53 787.86 n/m 2.14 86.16
INO INOVIO PHARMACEUTICALS INC 12.98 780.85 n/m 14.37 270.26
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

SRPT Ind Avg S&P 500
n/m 80.07 19.71

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs